Brimonidine Purite 0.15% Versus Dorzolamide 2% Used as Adjunctive Therapy to Latanoprost
NCT00348400
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
INDUSTRY
Sponsor class
Conditions
Glaucoma
Interventions
DRUG:
Brimonidine Purite 0.15%, Dorzolamide 2%, Latanoprost
Sponsor
Innovative Medical